An Update on the May 2026 Ruling on Mifepristone Access

Last updated: May 1, 2026

On May 1, 2026, the U.S. Court of Appeals for the 5th Circuit issued a ruling in Louisiana v. FDA.

We want our community to know where Southern Woven stands.

We are open and we are here

Our consultation process remains open. Our medical review process is ongoing. Our 24/7 medical support for enrolled patients is unchanged. Our sliding-scale fee structure ($0–145) is unchanged.

We are evaluating

Our clinical and legal teams are reviewing the ruling. We are coordinating with peer providers, partner organizations, and our legal counsel to determine the best path forward for our patients.

We will continue to provide care through whatever clinical and regulatory pathway is appropriate.

If you are already a Southern Woven patient

If you have an active consultation or care plan in progress, our team will reach out to you directly with guidance specific to your care. You can also message us through your patient portal or call the clinical support number on your prescription bottle, paperwork, or inside your portal. For general questions, email hello@southernwoven.com or call 845-THE-PILL.

If you are new and considering care

You can still start a consultation. During your medical review, our clinicians will discuss your specific care plan and answer your questions.

If you have legal questions

For questions about the legal landscape in your state, please contact the If/When/How Repro Legal Helpline at 844-868-2812. They provide free, confidential legal information.

Stay updated

We will update this page as the situation develops.

If you have questions, reach our team at hello@southernwoven.com.